What is Capgemini’s focus at the Fierce JPM Week Conference 2026?

Capgemini will showcase its latest research report, “Smart bet, only option or both? Biopharma R&D turns to AI,” which will be launched during JPM Week. The report explores how AI, including Generative AI and Agentic AI, is transforming biopharma R&D.

Is registration required for the Fierce JPM Week Conference?

Yes. The Fierce JPM Week Conference is a paid event, and attendees must purchase a ticket to participate.

How does Capgemini support pharma pipeline acceleration?

Capgemini offers a comprehensive suite of AI-driven services, including AI, Generative AI, and Agentic AI solutions—to help pharmaceutical companies accelerate clinical development and optimize their R&D pipelines.

Fierce JPM week

Discover how AI is transforming pharma R&D – Join Capgemini at Fierce JPM week

Your business challenges have answers.

Connect with us at Fierce Pharma’s JPM Week Conference and see how Capgemini is helping life sciences organizations innovate their way to a better future.

As a marquee sponsor, we’re unveiling new industry research during our keynote on Tuesday 13^th January at 9:00 AM

Keynote: Smart bet, only option, or both? Pharma R&D turns to AI

Join Thorsten Rall for an exclusive look at new Capgemini Research Institute findings on how AI is redefining biopharma R&D, plus real-world use cases and scaling strategies.

Secure your spot at Fierce JPM week

“Registration is managed by Fierce Pharma”

Why attend Capgemini’s session?

Exclusive launch of new Capgemini Research Institute report
Insights on Generative AI and Agentic AI in biopharma R&D
Practical strategies for scaling AI in clinical development

Meet our experts

Since January 2023, Thorsten has been the Executive Vice President and Global Industry Lead for Life Sciences at Capgemini. Previously, he worked at Novartis in various senior roles. As Senior Vice President of Digital Transformation & Innovation, he led the digital function, developed and implemented high-risk, high-return strategic innovation initiatives, and was responsible for Business Development and partnerships in the digital space.

Connect with us

First name *

First name is not valid.

Last name *

Last name is not valid.

Company email *

Company email is not valid.

Company *

Company is not valid.

Country

Country is not valid.

Phone (optional)

Your message *

Your message is not valid.

Page title

Expert title

Page URL

Slide to submit

Thank you for your submission. We will be in touch with you soon!

We are sorry, the form submission failed. Please try again.

Connect with us

First name *

First name is not valid.

Last name *

Last name is not valid.

Company email *

Company email is not valid.

Company *

Company is not valid.

Country

Country is not valid.

Phone (optional)

Your message *

Your message is not valid.

Page title

Expert title

Page URL

Slide to submit

Thank you for your submission. We will be in touch with you soon!

We are sorry, the form submission failed. Please try again.

With 16 years of experience, Barnabé is a seasoned leader in strategy, data, and operations in Life Sciences. Before Capgemini, he worked at Ipsen Pharma as Director of Strategic Planning and at Air Liquide Healthcare, where he was BU Head in Renal Care and Digital Strategy Director for chronic diseases. At Capgemini, he leads the Life Sciences incubator for Invent, focusing on Data and AI services in R&D. He is the author of the Capgemini annual barometer “AI for Health” and delivers regular thought leadership on Data and AI in the sector.